Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-27
DOI
10.1007/s10549-021-06259-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence (mIHC/IF)
- (2021) Tracy Zhijun Tien et al. HISTOPATHOLOGY
- Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
- (2020) Guoxuan Gao et al. BMC CANCER
- Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
- (2020) Francesca Sanges et al. BMC CANCER
- How to treat lobular cancer in the adjuvant setting?
- (2020) Dario Trapani et al. CURRENT OPINION IN ONCOLOGY
- Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
- (2020) Antonio Marra et al. npj Breast Cancer
- Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis
- (2020) Yiqun Han et al. BREAST
- Clinical outcomes and patterns of care in the treatment of carcinosarcoma of the breast
- (2019) William R. Kennedy et al. Cancer Medicine
- HER2+ and triple-negative phenotypes in invasive lobular carcinoma might have different specific biological features
- (2019) Kadri Altundag BREAST CANCER RESEARCH AND TREATMENT
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- ICD-11
- (2019) The Lancet LANCET
- Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
- (2019) Akira I. Hida et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic landscape of metaplastic breast cancer
- (2019) N. Tray et al. CANCER TREATMENT REVIEWS
- Predictive and prognostic value of stromal tumour-infiltrating lymphocytes before and after neoadjuvant therapy in triple negative and HER2-positive breast cancer
- (2019) Tomohiro Ochi et al. EUROPEAN JOURNAL OF CANCER
- The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis
- (2019) Joseph C Del Paggio et al. LANCET ONCOLOGY
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
- (2019) J H Park et al. ANNALS OF ONCOLOGY
- Comparison of outcomes between metaplastic and triple-negative breast cancer patients
- (2019) Praveen Polamraju et al. BREAST
- Molecular stratification within triple-negative breast cancer subtypes
- (2019) Dong-Yu Wang et al. Scientific Reports
- Squamous cell carcinoma of the breast: A retrospective study
- (2018) Maher Soliman Journal of Cancer Research and Therapeutics
- Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality
- (2018) Sofia Sideri et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy
- (2018) S J Luen et al. ANNALS OF ONCOLOGY
- Clinicopathological characteristics and prognosis of metaplastic carcinoma of the breast
- (2017) Meng Xiao et al. Oncology Letters
- Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor–Positive Subset of Triple-Negative Breast Cancers
- (2016) Anne M. Mills et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Chemotherapy Significantly Improves Survival for Patients with T1c-T2N0M0 Medullary Breast Cancer: 3739 Cases From the National Cancer Data Base
- (2016) Alina M. Mateo et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic and predictive value of tumor infiltrating lymphocytes in early breast cancer
- (2016) Carmen Criscitiello et al. CANCER TREATMENT REVIEWS
- Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant Setting
- (2016) Luisa Carbognin et al. ONCOLOGIST
- Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer
- (2015) Adnan Aydiner et al. MEDICINE
- Snowballing citations
- (2015) Helen H G Handoll et al. BMJ-British Medical Journal
- Snowballing citations
- (2015) Helen H G Handoll et al. BMJ-British Medical Journal
- Immunoscoring breast cancer: TILs remember what they target
- (2014) G. Curigliano et al. ANNALS OF ONCOLOGY
- Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast
- (2014) Jing Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study
- (2014) E A Rakha et al. BRITISH JOURNAL OF CANCER
- Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
- (2014) M. D. Burstein et al. CLINICAL CANCER RESEARCH
- Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities
- (2014) M. V. Dieci et al. ONCOLOGIST
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Rare Breast Cancer: 933 Adenoid Cystic Carcinomas from the National Cancer Data Base
- (2013) Nandini Kulkarni et al. ANNALS OF SURGICAL ONCOLOGY
- Tackling the Diversity of Triple-Negative Breast Cancer
- (2013) N. C. Turner et al. CLINICAL CANCER RESEARCH
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: The relationship between the outcome and the clinicopathological characteristics
- (2012) Tomoya Nagao et al. BREAST
- FGFR Signaling Promotes the Growth of Triple-Negative and Basal-Like Breast Cancer Cell Lines Both In Vitro and In Vivo
- (2011) Rachel Sharpe et al. CLINICAL CANCER RESEARCH
- Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer
- (2011) Stacy Moulder et al. JOURNAL OF CLINICAL ONCOLOGY
- Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers
- (2011) Daniel Wetterskog et al. JOURNAL OF PATHOLOGY
- Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer
- (2010) Abigail S. Caudle et al. ANNALS OF SURGICAL ONCOLOGY
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
- (2009) B. T. Hennessy et al. CANCER RESEARCH
- Refinement of breast cancer classification by molecular characterization of histological special types
- (2008) B Weigelt et al. JOURNAL OF PATHOLOGY
- Breast cancer special types: why bother?
- (2008) JS Reis-Filho et al. JOURNAL OF PATHOLOGY
- Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum
- (2008) Marick Laé et al. MODERN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search